Wednesday, April 20, 2016 - Friday, April 21, 2017 12:00 AM
At the conclusion of this activity, participants should be able to:
- To place the discovery of hepatitis B and hepatitis C viruses into historical perspective;
- To understand the interventions that have reduced post-transfusion hepatitis incidence from 30% in 1970 to near zero today; and
- To learn the natural history, severe outcomes and treatment options for chronic hepatitis C.
Indiana University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Indiana University School of Medicine designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credits
™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.